{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T07:26:44Z","timestamp":1769930804836,"version":"3.49.0"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,5,15]]},"DOI":"10.2169\/internalmedicine.0269-22","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T22:13:19Z","timestamp":1663020799000},"page":"1527-1530","source":"Crossref","is-referenced-by-count":3,"title":["Triple-negative Thrombocythemia and Subsequent Acute Lymphoblastic Leukemia with Additional Somatic Mutations"],"prefix":"10.2169","volume":"62","author":[{"given":"Yuri","family":"Tsuboi","sequence":"first","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"},{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Makishima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Suehara","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"},{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kurita","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"},{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"},{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayasu","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"},{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Nishikii","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"},{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoshi","family":"Obara","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"},{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"},{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamiko","family":"Sakata-Yanagimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"},{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan"},{"name":"Division of Advanced Hemato-Oncology, Transborder Medical Research Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Swerdllow S, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization, 2017."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv 5: 1059-1068, 2021.","DOI":"10.1182\/bloodadvances.2020003172"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cerquozzi S, Tefferi A. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J 5: e366, 2015.","DOI":"10.1038\/bcj.2015.95"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hashimoto Y, Ito T, Gotoh A, et al. Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study. Int J Hematol 115: 208-221, 2022.","DOI":"10.1007\/s12185-021-03253-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 81: 159-166, 2006.","DOI":"10.4065\/81.2.159"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Andersson PO, Ridell B, Wadenvik H, Kutti J. Leukemic transformation of essential thrombocythemia without previous cytoreductive treatment. Ann Hematol 79: 40-42, 2000.","DOI":"10.1007\/s002770050007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Luque Paz D, Jouanneau-Courville R, Riou J, et al. Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation. Blood Adv 4: 4887-4897, 2020.","DOI":"10.1182\/bloodadvances.2020002271"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. McNamara CJ, Panzarella T, Kennedy JA, et al. The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes. Blood Adv 2: 2658-2671, 2018.","DOI":"10.1182\/bloodadvances.2018021469"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tao J, Zhang X, Lancet J, et al. Concurrence of B-lymphoblastic leukemia and myeloproliferative neoplasm with copy neutral loss of heterozygosity at chromosome 1p harboring a <i>MPL<\/i> W515S mutation. Cancer Genet 207: 489-494, 2014.","DOI":"10.1016\/j.cancergen.2014.10.001"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Porpaczy E, Tripolt S, Hoelbl-Kovacic A, et al. Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1\/2 inhibitor therapy. Blood 132: 694-706, 2018.","DOI":"10.1182\/blood-2017-10-810739"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Argiropoulos B, Yung E, Humphries RK. Unraveling the crucial roles of <i>Meis1<\/i> in leukemogenesis and normal hematopoiesis. Genes Dev 21: 2845-2849, 2007.","DOI":"10.1101\/gad.1619407"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Denslow SA, Wade PA. The human Mi-2\/NuRD complex and gene regulation. Oncogene 26: 5433-5438, 2007.","DOI":"10.1038\/sj.onc.1210611"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zhan D, Zhang Y, Xiao P, et al. Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia. Leuk Res 65: 20-24, 2018.","DOI":"10.1016\/j.leukres.2017.12.001"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Chen J, Gao XM, Zhao H, et al. A highly heterogeneous mutational pattern in POEMS syndrome. Leukemia 35: 1100-1107, 2021.","DOI":"10.1038\/s41375-020-01101-4"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 28: 241-247, 2014.","DOI":"10.1038\/leu.2013.336"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Liu Z, Zhang J, Sun Y, Perea-Chamblee TE, Manley JL, Rabadan R. Pan-cancer analysis identifies mutations in <i>SUGP1<\/i> that recapitulate mutant SF3B1 splicing dysregulation. Proc Natl Acad Sci U S A 117: 10305-10312, 2020.","DOI":"10.1073\/pnas.1922622117"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/10\/62_0269-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:32:11Z","timestamp":1715315531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/10\/62_0269-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0269-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"article-number":"0269-22"}}